Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Splicing intervention for Duchenne muscular dystrophy.

Graham McClorey¹, Susan Fletcher, Stephen Wilton

¹Centre for Neurological and Neuromuscular Disorders, Australian Neuromuscular Research Institute, University of Western Australia, QEII Medical Centre, Nedlands WA 6009, Australia.

Current Opinion in Pharmacology

|August 9, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structured Online Support to Inform and Assist Antidepressant Deprescribing in Primary Care: Protocol for a Pragmatic, Randomized Controlled Trial (The WiserAD Trial).

JMIR research protocols·2026

Same author

Paraspeckle condensation is controlled via TDP-43 polymerization and linked to neuroprotection.

Nature cell biology·2026

Same author

Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial.

Nature medicine·2026

Same author

Predictors and Outcomes Associated with Clinically Significant Improvements in Anxiety and Depression Symptoms Following Cardiac Rehabilitation.

The Canadian journal of cardiology·2025

Same author

Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy.

Nature neuroscience·2025

Same author

Mortality and Graft Failure With Medical Management Alone Versus Revascularization After Coronary Angiography Among Kidney Transplant Recipients: A Population-Based Study.

Canadian journal of kidney health and disease·2025

Gene transcript splicing modulation, particularly exon skipping, shows promise for treating genetic disorders like Duchenne muscular dystrophy (DMD). This approach could convert severe DMD phenotypes into milder Becker-like ones, paving the way for clinical trials.

Area of Science:

Genetics
Molecular Biology
Biotechnology

Background:

Genetic disorders can arise from mutations affecting gene splicing.
Duchenne muscular dystrophy (DMD) is a severe genetic disorder with limited treatment options.

Purpose of the Study:

To explore the potential of pre-mRNA splicing modulation for treating genetic disorders.
To investigate exon skipping as a strategy to correct disease-causing mutations in DMD.

Main Methods:

Targeted removal of specific exons from gene transcripts.
Utilizing antisense oligonucleotides for exon skipping induction.
In vivo and in vitro studies in animal models and cell lines.

Main Results:

Related Experiment Videos

Demonstrated successful induction of exon skipping.

Achieved restoration of dystrophin expression in DMD models.

Converted DMD phenotype towards a Becker-like phenotype.

Conclusions:

Splicing modulation, specifically exon skipping, is a promising therapeutic strategy for DMD.
This approach has the potential to convert severe DMD phenotypes into milder forms.
Human clinical trials for this exon-skipping therapy are anticipated in the near future.